NASDAQ : AKAN
Akanda Corp. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 1.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.75M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Details
| Name | Akanda Corp. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 46 |
| Founded | 2021 |
| Ipo Date | 2022-03-15 |
| Ceo | Christopher Cooper |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.00 |
| Isin | CA00971M7008 |
| Cusip | 00971M700 |
| Cik | 1888014 |
| Sic | 4899 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Christopher Robert Cooper BBA, M.B.A. | Chief Executive Officer and Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
| Edgar Contreras | Country Manager of First Towers |
| Francisco Juarez | Vice President, Chief Operating Officer and Director of First Towers |
Contact
| Address | 100 King St. W, Suite 1600, Toronto, ON M5X 1G5, Canada |
| Phone | 416 862 7525 |
| Website | https://www.akandacorp.com |